We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

GE Gets Final Approvals for Instrumentarium Acquisition

By HospiMedica staff writers
Posted on 03 Oct 2003
The remaining regulatory approvals required for its acquisition of Instrumentarium Corp. (Helsinki, Finland) have been received by GE Medical Systems (Waukesha, WI, USA), according to a GE announcement.

These approvals include those of the US Department of Justice and the Canadian Competition Bureau. The European Commission had previously announced approval. GE's tender offer for all Instrumentarium shares and options is set to expire on September 30, 2003. In order to address issues raised by regulators, GE has agreed to divest the Ziehm surgical C-arm business of Instrumentarium. The company has also reconfirmed its agreement with the European Commission to divest the Spacelabs patient monitoring business and to maintain on a global basis the current practice of GE and Instrumentarium of open interfaces for the products covered by the commitments.

GE states that it will announce the results of the company's tender offer on or about October 6, 2003. If the minimum acceptance level is met, tendering shareholders and option holders will receive payment of the offer price on or about October 14, 2003.





Related Links:
Instrumentarium
GE Medical Systems

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Digital Radiography System
DigiEye 680
New
6-Channel ECG System
SE600

Latest Business News

Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights

Arab Health 2025 Celebrates Landmark 50th Edition

Boston Scientific Acquires Medical Device Company Intera Oncology